GlassScriptPhysician profile
John R Walters
NPI 1124169511
$5,816.96
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,034 · 2020: $820 · 2021: $1,450 · 2022: $1,315 · 2023: $1,153 · 2024: $44.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,197.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $1,519.88 | 2019-2023 | Cequa, Xelpros |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $882.98 | 2019-2021 | |
| Sight Sciences, INC. | $475.99 | 2022-2024 | Omni Surgical System |
| Alcon Vision LLC | $410.99 | 2019-2024 | Clareon, Rocklatan, Centurion |
| Mallinckrodt Hospital Products INC. | $364.67 | 2020-2022 | |
| Kala Pharmaceuticals, INC. | $362.90 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $354.13 | 2022-2023 | Xiidra, Vyzulta |
| Aerie Pharmaceuticals, INC. | $350.54 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $253.34 | 2019-2023 | |
| Allergan, INC. | $146.13 | 2020-2022 | |
| Abbvie INC. | $129.93 | 2022-2023 | Lumigan, Alphagan P |
| New World Medical,INC. | $73.59 | 2023 | |
| Ivantis, INC | $67.79 | 2021 | |
| Glaukos Corporation | $65.40 | 2021 | |
| Biotissue Holdings INC. | $60.82 | 2020-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $59.14 | 2022-2023 | Tyrvaya |
| Akorn, INC. | $41.80 | 2020 | |
| Mallinckrodt Enterprises LLC | $37.89 | 2019 | |
| Shire North American Group INC | $37.54 | 2019 | |
| Omeros Corporation | $31.17 | 2019-2020 | |
| Horizon Therapeutics Plc | $30.13 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $28.13 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $16.51 | 2023 | Cirrus Hd-Oct |
| Ocular Therapeutix, INC. | $15.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.